Literature DB >> 8676076

Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.

A L Petzer1, P W Zandstra, J M Piret, C J Eaves.   

Abstract

A high proportion of the CD34+CD38- cells in normal human marrow are defined as long-term culture-initiating cells (LTC-IC) because they can proliferate and differentiate when co-cultured with cytokine-producing stromal feeder layers. In contrast, very few CD34+CD38- cells will divide in cytokine-containing methylcellulose and thus are not classifiable as direct colony-forming cells (CFC), although most can proliferate in serum-free liquid cultures containing certain soluble cytokines. Analysis of the effects of 16 cytokines on CD34+CD38- cells in the latter type of culture showed that Flt3-ligand (FL), Steel factor (SF), and interleukin (IL)-3 were both necessary and sufficient to obtain an approximately 30-fold amplification of the input LTC-IC population within 10 d. As single factors, only FL and thrombopoietin (TPO) stimulated a net increase in LTC-IC within 10 d. Interestingly, a significantly increased proportion of the CFC produced from the TPO-amplified LTC-IC were erythroid. Increases in the number of directly detectable CFC of > 500-fold were also obtainable within 10 d in serum-free cultures of CD34+CD38- cells. However, this required the presence of IL-6 and/or granulocyte/colony-stimulating factor and/or nerve growth factor beta in addition to FL, SF, and IL-3. Also, for this response, the most potent single-acting factor tested was IL-3, not FL. Identification of cytokine combinations that differentially stimulate primitive human hematopoietic cell self-renewal and lineage determination should facilitate analysis of the intracellular pathways that regulate these decisions as well as the development of improved ex vivo expansion and gene transfer protocols.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676076      PMCID: PMC2192600          DOI: 10.1084/jem.183.6.2551

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Ex vivo expansion of cord blood-derived stem cells and progenitors.

Authors:  M A Moore; I Hoskins
Journal:  Blood Cells       Date:  1994

2.  Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Authors:  G Sauvageau; P M Lansdorp; C J Eaves; D E Hogge; W H Dragowska; D S Reid; C Largman; H J Lawrence; R K Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 3.  Differentiation and proliferation of hematopoietic stem cells.

Authors:  M Ogawa
Journal:  Blood       Date:  1993-06-01       Impact factor: 22.113

4.  The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors.

Authors:  F Hirayama; S D Lyman; S C Clark; M Ogawa
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

5.  Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures.

Authors:  M R Koller; S G Emerson; B O Palsson
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

6.  STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.

Authors:  D Small; M Levenstein; E Kim; C Carow; S Amin; P Rockwell; L Witte; C Burrow; M Z Ratajczak; A M Gewirtz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells.

Authors:  A Hattori; E Tanaka; K Murase; N Ishida; Y Chatani; M Tsujimoto; K Hayashi; M Kohno
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

8.  FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.

Authors:  M O Muench; M G Roncarolo; S Menon; Y Xu; R Kastelein; S Zurawski; C H Hannum; J Culpepper; F Lee; R Namikawa
Journal:  Blood       Date:  1995-02-15       Impact factor: 22.113

9.  Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells.

Authors:  P W Zandstra; C J Eaves; J M Piret
Journal:  Biotechnology (N Y)       Date:  1994-09

10.  Long-term erythropoiesis from constant numbers of CD34+ cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow.

Authors:  P M Lansdorp; W Dragowska
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  45 in total

1.  Cell cycle distribution of primitive haematopoietic cells stimulated in vitro and in vivo.

Authors:  X W Zhang; J Audet; J M Piret; Y X Li
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

2.  Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

Authors:  E Conneally; J Cashman; A Petzer; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

3.  Ex vivo expansion of human umbilical cord blood CD34+ cells in a collagen bead-containing 3-dimensional culture system.

Authors:  Han-Soo Kim; Jong Baeck Lim; Yoo Hong Min; Seung Tae Lee; Chuhl Joo Lyu; Eun Seok Kim; Hyun Ok Kim
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.490

4.  Stem cell technology. Interview by Abi Berger.

Authors:  P A Fontes; A W Thomson
Journal:  BMJ       Date:  1999-11-13

Review 5.  Hematopoietic stem cells.

Authors:  Robert G Hawley; Ali Ramezani; Teresa S Hawley
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

6.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

Review 7.  An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Authors:  Abhishek Kumar Singh; Mahendra Pratap Kashyap
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

Review 8.  Regulation of stress-induced hematopoiesis.

Authors:  Jimmy L Zhao; David Baltimore
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

9.  Distinct signaling programs control human hematopoietic stem cell survival and proliferation.

Authors:  David J H F Knapp; Colin A Hammond; Nima Aghaeepour; Paul H Miller; Davide Pellacani; Philip A Beer; Karen Sachs; Wenlian Qiao; WeiJia Wang; R Keith Humphries; Guy Sauvageau; Peter W Zandstra; Sean C Bendall; Garry P Nolan; Carl Hansen; Connie J Eaves
Journal:  Blood       Date:  2016-11-08       Impact factor: 22.113

10.  Expansion of engrafting human hematopoietic stem/progenitor cells in three-dimensional scaffolds with surface-immobilized fibronectin.

Authors:  Qi Feng; Chou Chai; Xue-Song Jiang; Kam W Leong; Hai-Quan Mao
Journal:  J Biomed Mater Res A       Date:  2006-09-15       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.